Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Otorhinolaryngology

Free Subscription Articles published in Cancer Retrieve available abstracts of 68 articles: HTML format

Single Articles

January 2025
1. KHANNA D, Mishra A, Birur P, Shruti T, et al
   A prospective study on diagnostic accuracy of technology-enabled early detection of oral cancer and epidemiology of tobacco and other substances use in rural India.
   Cancer. 2025;131:e35702.
   PubMed     Abstract available
   
   
   December 2024
2. NGUYEN T, Koric A, Chang CE, Barul C, et al
   Coffee and tea consumption and the risk of head and neck cancer: An updated pooled analysis in the International Head and Neck Cancer Epidemiology Consortium.
   Cancer. 2024 Dec 23. doi: 10.1002/cncr.35620.
   PubMed     Abstract available
   
   
   
3. NIERENGARTEN MB
   First person profile: Quynh-Thu Le, MD: Dr Le confronts the difficult challenges of improving the efficacy and safety of radiation therapy in the treatment of head and neck cancers.
   Cancer. 2024;130:4164.
   PubMed    
   
   
   
4. NIERENGARTEN MB
   Promising long-term disease control and survival with pembrolizumab and cabozantinib for head and neck cancer.
   Cancer. 2024;130:3947.
   PubMed    
   
   
   
5. NIERENGARTEN MB
   Increased head and neck cancer linked to cannabis use.
   Cancer. 2024;130:3946.
   PubMed    
   
   
   November 2024
6. DAY AT, Mitchell DN, Eary RL, Jones E, et al
   Considerations in screening for asymptomatic carotid artery stenosis in irradiated head and neck cancer survivors.
   Cancer. 2024 Nov 26. doi: 10.1002/cncr.35639.
   PubMed    
   
   
   
7. BERZENJI D, Oude Booijink ORG, Gahrmann R, Mast H, et al
   A comprehensive approach to defining the cutoff value of oligometastasis in head and neck squamous cell carcinoma.
   Cancer. 2024 Nov 5. doi: 10.1002/cncr.35632.
   PubMed     Abstract available
   
   
   August 2024
8. WU Q, Hu C, Feng L, Yang X, et al
   Comprehensive genomic profiling of infiltrative follicular variant of papillary thyroid carcinoma.
   Cancer. 2024 Aug 14. doi: 10.1002/cncr.35517.
   PubMed     Abstract available
   
   
   July 2024
9. SALZ T, Meza AM, Bradshaw PT, Jinna S, et al
   Role of primary care in opioid prescribing for older head and neck cancer survivors.
   Cancer. 2024 Jul 27. doi: 10.1002/cncr.35478.
   PubMed     Abstract available
   
   
   June 2024
10. NIERENGARTEN MB
    First person profile: Everett Vokes, MD: Pioneer of the combination of radiation and chemotherapy as the first line of treatment for head and neck cancer.
    Cancer. 2024;130:2082-2083.
    PubMed    
    
    
    
11. NIERENGARTEN MB
    FDA approves first immunotherapy drug for nasopharyngeal carcinoma.
    Cancer. 2024;130:1903.
    PubMed    
    
    
    May 2024
12. NING T, Li D, Deng T, Bai Y, et al
    Anti-PD-L1 antibody TQB2450 combined with tyrosine kinase receptor inhibitor AL2846 for immunotherapy-refractory advanced hepatocellular carcinoma and esophageal squamous cell carcinoma: A prospective phase 1b cohort study.
    Cancer. 2024 May 23. doi: 10.1002/cncr.35377.
    PubMed     Abstract available
    
    
    
13. NIERENGARTEN MB
    First person profile: Barbara Burtness, MD: For more than 20 years, she has applied advances in molecular biology to better treat patients with head and neck cancers.
    Cancer. 2024;130:1724.
    PubMed    
    
    
    March 2024
14. CONTRERA KJ, Patel MR, Burtness B, Mehra R, et al
    The role of surgery and deescalation for HPV-related oropharyngeal cancer.
    Cancer. 2024 Mar 18. doi: 10.1002/cncr.35287.
    PubMed     Abstract available
    
    
    February 2024
15. CHOI H, Cho SW, Kim HH, Yi KH, et al
    Shortened telomere length in peripheral blood leukocytes is associated with cumulative radioactive iodine doses in patients with differentiated thyroid carcinoma.
    Cancer. 2024 Feb 20. doi: 10.1002/cncr.35256.
    PubMed     Abstract available
    
    
    January 2024
16. GROSS ND, Seiwert TY
    Neoadjuvant immunotherapy is safe before surgery in head and neck squamous cell carcinoma. Is it time to challenge the standard-of-care?
    Cancer. 2024 Jan 18. doi: 10.1002/cncr.35198.
    PubMed    
    
    
    
17. NIERENGARTEN MB
    Novel biomarker significantly improves diagnostic accuracy for nasopharyngeal cancer.
    Cancer. 2024;130:172.
    PubMed    
    
    
    
18. NIERENGARTEN MB
    Oral health linked to survival in head and neck cancer.
    Cancer. 2024;130:171.
    PubMed    
    
    
    December 2023
19. 
    Researchers identify two new subtypes of HPV-associated head and neck cancers.
    Cancer. 2023;129:3842.
    PubMed    
    
    
    October 2023
20. CARPENTER DJ, Patel P, Niedzwiecki D, Dillon M, et al
    Long-term risk of carotid stenosis and cerebrovascular disease after radiation therapy for head and neck cancer.
    Cancer. 2023 Oct 28. doi: 10.1002/cncr.35089.
    PubMed     Abstract available
    
    
    
21. PHILIPS R, Alnemri A, Amin D, Patel J, et al
    Effect of preoperative programmed death-1 or programmed death ligand-1 immune check point inhibition on complications after surgery for primary head and neck cancer.
    Cancer. 2023 Oct 3. doi: 10.1002/cncr.35045.
    PubMed     Abstract available
    
    
    September 2023
22. FUNT SA, Knezevic A, Wilson K, Bromberg M, et al
    Ototoxicity associated with high-dose carboplatin for patients with previously treated germ cell tumors.
    Cancer. 2023 Sep 16. doi: 10.1002/cncr.34991.
    PubMed     Abstract available
    
    
    
23. ZHANG L, San Valentin EMD, John TM, Jenq RR, et al
    Influence of oral microbiome on longitudinal patterns of oral mucositis severity in patients with squamous cell carcinoma of the head and neck.
    Cancer. 2023 Sep 8. doi: 10.1002/cncr.35001.
    PubMed     Abstract available
    
    
    July 2023
24. PATEL SA, Gibson MK, Deal A, Sheth S, et al
    A phase 2 study of neoadjuvant chemotherapy plus durvalumab in resectable locally advanced head and neck squamous cell carcinoma.
    Cancer. 2023 Jul 3. doi: 10.1002/cncr.34930.
    PubMed     Abstract available
    
    
    May 2023
25. HARING CT, Kana LA, Dermody SM, Brummel C, et al
    Patterns of recurrence in head and neck squamous cell carcinoma to inform personalized surveillance protocols.
    Cancer. 2023 May 10. doi: 10.1002/cncr.34823.
    PubMed     Abstract available
    
    
    
26. 
    Erratum to "Concordance in postsurgical radioactive iodine therapy recommendations between Watson for Oncology and clinical practice in patients with differentiated thyroid carcinoma".
    Cancer. 2023 May 2. doi: 10.1002/cncr.34829.
    PubMed    
    
    
    
27. RAMKUMAR SP, Simpson MC, Adjei Boakye E, Bukatko AR, et al
    High-risk human papillomavirus 16/18 associated with improved survival in sinonasal squamous cell carcinoma.
    Cancer. 2023;129:1372-1383.
    PubMed     Abstract available
    
    
    April 2023
28. YAN L, Li Y, Li XY, Xiao J, et al
    Clinical outcomes of ultrasound-guided radiofrequency ablation for solitary T1N0M0 papillary thyroid carcinoma: A retrospective study with more than 5 years of follow-up.
    Cancer. 2023 Apr 15. doi: 10.1002/cncr.34802.
    PubMed     Abstract available
    
    
    
29. D'SOUZA G, Tewari SR, Troy T, Waterboer T, et al
    Prevalence of oral and blood oncogenic human papillomavirus biomarkers among an enriched screening population: Baseline results of the MOUTH study.
    Cancer. 2023 Apr 9. doi: 10.1002/cncr.34783.
    PubMed     Abstract available
    
    
    February 2023
30. QUAN DL, Grauer JS, Sunkara PR, Cramer JD, et al
    Surgical salvage of human papillomavirus-positive oropharyngeal cancer: Secondary analysis of a randomized controlled trial.
    Cancer. 2023;129:376-384.
    PubMed     Abstract available
    
    
    January 2023
31. VERMA A, Burtness B
    Top advances of the year: Head and neck cancer.
    Cancer. 2023 Jan 24. doi: 10.1002/cncr.34654.
    PubMed     Abstract available
    
    
    
32. LEE JJW, Kunaratnam V, Kim CJH, Pienkowski M, et al
    Cigarette smoking cessation, duration of smoking abstinence, and head and neck squamous cell carcinoma prognosis.
    Cancer. 2023 Jan 18. doi: 10.1002/cncr.34620.
    PubMed     Abstract available
    
    
    November 2022
33. KOYUNCU CF, Nag R, Lu C, Corredor G, et al
    Image analysis reveals differences in tumor multinucleations in Black and White patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    Cancer. 2022;128:3831-3842.
    PubMed     Abstract available
    
    
    October 2022
34. 
    Sharp rise in esophageal cancer and Barrett esophagus seen in middle-aged people.
    Cancer. 2022;128:3584-3585.
    PubMed    
    
    
    August 2022
35. LIN Y, Bruner DW, Paul S, Miller AH, et al
    A network analysis of self-reported psychoneurological symptoms in patients with head and neck cancer undergoing intensity-modulated radiotherapy.
    Cancer. 2022 Aug 15. doi: 10.1002/cncr.34424.
    PubMed     Abstract available
    
    
    July 2022
36. MAZUL AL, Hartman CM, Mowery YM, Kramer JR, et al
    Risk and incidence of head and neck cancers in veterans living with HIV and matched HIV-negative veterans.
    Cancer. 2022 Jul 22. doi: 10.1002/cncr.34387.
    PubMed     Abstract available
    
    
    
37. HSUEH CY, Lau HC, Huang Q, Gong H, et al
    Fusobacterium nucleatum impairs DNA mismatch repair and stability in patients with squamous cell carcinoma of the head and neck.
    Cancer. 2022 Jul 5. doi: 10.1002/cncr.34338.
    PubMed     Abstract available
    
    
    June 2022
38. 
    Erratum to "Remote triage incorporating symptom-based risk stratification for suspected head and neck cancer referrals: A prospective population-based study".
    Cancer. 2022 Jun 24. doi: 10.1002/cncr.34358.
    PubMed    
    
    
    
39. O'BOYLE CJ, Siravegna G, Varmeh S, Queenan N, et al
    Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancer.
    Cancer. 2022;128:2193-2204.
    PubMed     Abstract available
    
    
    May 2022
40. HUANG SH, Jacinto JCK, O'Sullivan B, Su J, et al
    Clinical presentation and outcome of human papillomavirus-positive nasopharyngeal carcinoma in a North American cohort.
    Cancer. 2022 May 19. doi: 10.1002/cncr.34266.
    PubMed     Abstract available
    
    
    
41. NELSON TJ, Thompson CA, Zou J, Kumar A, et al
    Validation of NRG Oncology's prognostic nomograms for oropharyngeal cancer in the Veterans Affairs database.
    Cancer. 2022;128:1948-1957.
    PubMed     Abstract available
    
    
    April 2022
42. HUTCHESON KA, Barbon CEA, Alvarez CP, Warneke CL, et al
    Refining measurement of swallowing safety in the Dynamic Imaging Grade of Swallowing Toxicity (DIGEST) criteria: Validation of DIGEST version 2.
    Cancer. 2022;128:1458-1466.
    PubMed     Abstract available
    
    
    March 2022
43. PARK S, Oh D, Choi YL, Chi SA, et al
    Durvalumab and tremelimumab with definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
    Cancer. 2022 Mar 23. doi: 10.1002/cncr.34176.
    PubMed     Abstract available
    
    
    
44. SOO J, Jin MC, Beadle BM, Holsinger FC, et al
    Circulating tumor DNA in head and neck cancer: Early successes and future promise.
    Cancer. 2022 Mar 17. doi: 10.1002/cncr.34189.
    PubMed     Abstract available
    
    
    February 2022
45. EKANAYAKE WEERAMANGE C, Shu D, Tang KD, Batra J, et al
    Analysis of human leukocyte antigen associations in human papillomavirus-positive and -negative head and neck cancer: Comparison with cervical cancer.
    Cancer. 2022 Feb 17. doi: 10.1002/cncr.34148.
    PubMed     Abstract available
    
    
    
46. OLIVER JR, Persky MJ, Wang B, Duvvuri U, et al
    Transoral robotic surgery adoption and safety in treatment of oropharyngeal cancers.
    Cancer. 2022;128:685-696.
    PubMed     Abstract available
    
    
    
47. SCOTT-WITTENBORN N, D'Souza G, Tewari S, Rooper L, et al
    Prevalence of human papillomavirus in head and neck cancers at tertiary care centers in the United States over time.
    Cancer. 2022 Feb 8. doi: 10.1002/cncr.34124.
    PubMed     Abstract available
    
    
    December 2021
48. LIANG L, Liu Z, Zhu H, Wang H, et al
    Efficacy and safety of thalidomide in preventing oral mucositis in patients with nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy: A multicenter, open-label, randomized controlled trial.
    Cancer. 2021 Dec 15. doi: 10.1002/cncr.34074.
    PubMed     Abstract available
    
    
    
49. WOTMAN MT, Miles BA, Bakst RL, Posner MR, et al
    A proposal for risk-based and strategy-adapted de-escalation in human papillomavirus-positive oropharyngeal squamous cell carcinoma.
    Cancer. 2021;127:4330-4338.
    PubMed    
    
    
    
50. AGGARWAL P, Hutcheson KA, Garden AS, Mott FE, et al
    Determinants of patient-reported xerostomia among long-term oropharyngeal cancer survivors.
    Cancer. 2021;127:4470-4480.
    PubMed     Abstract available
    
    
    October 2021
51. TREISTER NS, Brennan MT, Sollecito TP, Schmidt BL, et al
    Exposed bone in patients with head and neck cancer treated with radiation therapy: An analysis of the Observational Study of Dental Outcomes in Head and Neck Cancer Patients (OraRad).
    Cancer. 2021 Oct 19. doi: 10.1002/cncr.33948.
    PubMed     Abstract available
    
    
    
52. REN J, Pang W, Hueniken K, Haddad G, et al
    Longitudinal health utility and symptom-toxicity trajectories in patients with head and neck cancers.
    Cancer. 2021 Oct 1. doi: 10.1002/cncr.33936.
    PubMed     Abstract available
    
    
    
53. FAKHRY C, Tewari SR, Zhang L, Windon MJ, et al
    RTOG-0129 risk groups are reproducible in a prospective multicenter heterogeneously treated cohort.
    Cancer. 2021;127:3523-3530.
    PubMed     Abstract available
    
    
    September 2021
54. ABDELMEGUID AS, Hanna EY
    Reply to Neoadjuvant chemotherapy for locoregionally advanced squamous cell carcinoma of the paranasal sinuses-Is it worthwhile?
    Cancer. 2021;127:3265.
    PubMed    
    
    
    
55. PANDA S, Raveendran S, Kumar R, Thakar A, et al
    Neoadjuvant chemotherapy for locoregionally advanced squamous cell carcinoma of the paranasal sinuses-Is it worthwhile?
    Cancer. 2021;127:3264.
    PubMed    
    
    
    
56. WU J, Xiao F, Zheng Y, Lin Y, et al
    Worldwide trend in human papillomavirus-attributable cancer incidence rates between 1990 and 2012 and Bayesian projection to 2030.
    Cancer. 2021;127:3172-3182.
    PubMed     Abstract available
    
    
    
57. RYAN WR, Xu MJ, Ochoa E, Plonowska-Hirschfeld KA, et al
    Oncologic outcomes of human papillomavirus-associated oropharynx carcinoma treated with surgery alone: A 12-institution study of 344 patients.
    Cancer. 2021;127:3092-3106.
    PubMed     Abstract available
    
    
    August 2021
58. GUO TW, Saiyed F, Yao CMKL, Kiong KL, et al
    Outcomes of patients with oropharyngeal squamous cell carcinoma treated with induction chemotherapy followed by concurrent chemoradiation compared with those treated with concurrent chemoradiation.
    Cancer. 2021;127:2916-2925.
    PubMed     Abstract available
    
    
    
59. SCHRANK TP, Lenze N, Landess LP, Hoyle A, et al
    Genomic heterogeneity and copy number variant burden are associated with poor recurrence-free survival and 11q loss in human papillomavirus-positive squamous cell carcinoma of the oropharynx.
    Cancer. 2021;127:2788-2800.
    PubMed     Abstract available
    
    
    July 2021
60. VAN DIJK LV, Mohamed ASR, Ferrarotto R, McCoy LA, et al
    The impact of induction and/or concurrent chemoradiotherapy on acute and late patient-reported symptoms in oropharyngeal cancer: Application of a mixed-model analysis of a prospective observational cohort registry.
    Cancer. 2021;127:2453-2464.
    PubMed     Abstract available
    
    
    
61. WHITMARSH A, Pring M, Thomas SJ, Waylen A, et al
    Survival advantage in patients with human papillomavirus-driven oropharyngeal cancer and variation by demographic characteristics and serologic response: Findings from Head and Neck 5000.
    Cancer. 2021;127:2442-2452.
    PubMed     Abstract available
    
    
    June 2021
62. SABA NF
    Preoperative chemotherapy for sinonasal squamous cell carcinoma (SNSCC): Time to move closer to a definitive answer.
    Cancer. 2021;127:1734-1735.
    PubMed    
    
    
    
63. ABDELMEGUID AS, Teeramatwanich W, Roberts DB, Amit M, et al
    Neoadjuvant chemotherapy for locoregionally advanced squamous cell carcinoma of the paranasal sinuses.
    Cancer. 2021;127:1788-1795.
    PubMed     Abstract available
    
    
    May 2021
64. JUNG YS, Seok J, Hong S, Ryu CH, et al
    The emergence of oral cavity cancer and the stabilization of oropharyngeal cancer: Recent contrasting epidemics in the South Korean population.
    Cancer. 2021;127:1638-1647.
    PubMed     Abstract available
    
    
    April 2021
65. DAHLSTROM KR, Song J, Thall PF, Fuller CD, et al
    Conditional survival among patients with oropharyngeal cancer treated with radiation therapy and alive without recurrence 5 years after diagnosis.
    Cancer. 2021;127:1228-1237.
    PubMed     Abstract available
    
    
    
66. DRAKE VE, Fakhry C, Windon MJ, Stewart CM, et al
    Timing, number, and type of sexual partners associated with risk of oropharyngeal cancer.
    Cancer. 2021;127:1029-1038.
    PubMed     Abstract available
    
    
    March 2021
67. BALACHANDRA S, Kusin SB, Lee R, Blackwell JM, et al
    Blood-based biomarkers of human papillomavirus-associated cancers: A systematic review and meta-analysis.
    Cancer. 2021;127:850-864.
    PubMed     Abstract available
    
    
    February 2021
68. HO AS, Luu M, Kim S, Tighiouart M, et al
    Nodal staging convergence for HPV- and HPV+ oropharyngeal carcinoma.
    Cancer. 2021 Feb 17. doi: 10.1002/cncr.33414.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Otorhinolaryngology is free of charge.